# CASSIPA
> **NDA208042** · New Drug Application · Sponsor: TEVA PHARMS USA · Approved 2018-09-07
## Drug
- **FDA Application Number:** NDA208042
- **Application type:** New Drug Application
- **Brand name:** CASSIPA
- **Generic name:** Buprenorphine Hydrochloride
- **Active ingredients:** BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
- **Dosage form:** FILM
- **Route:** SUBLINGUAL
- **Marketing status:** Discontinued
- **Sponsor:** TEVA PHARMS USA
- **First approval:** 2018-09-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208042)
---
*MORVS · CC0 1.0*